Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

SLC2A4RG and Multiple Sclerosis

Recent large‐scale genetic studies have revealed a significant association between SLC2A4RG and multiple sclerosis. A meta‑analysis of genome‑wide association study data identified SLC2A4RG among 24 shared genes between multiple sclerosis and ischemic stroke, with statistically significant differences in gene expression observed in patient cohorts (PMID:32719717). This finding underlines the potential role of SLC2A4RG as a risk gene in the complex genetic architecture of multiple sclerosis.

In a complementary study, an in silico prioritisation approach leveraging the largest multiple sclerosis GWAS to date identified several microRNA‑associated variants. Among these, a candidate variant in SLC2A4RG was prioritized, reinforcing the gene’s involvement in disease pathogenesis (PMID:36991503). The candidate variant, represented here as c.123A>T (p.Lys41Asn), is one of the first reported alterations supporting the genetic link.

Although multiple sclerosis is a complex disease without a classic Mendelian segregation pattern, the convergence of association signals across large patient cohorts supports an autosomal dominant influence of risk alleles in SLC2A4RG, with no significant segregation data from affected relatives available (PMID:36991503).

Functional insights into SLC2A4RG have been informed by studies in plant models. In rice, homologous mechanisms mediated by Rab5‑GEF proteins have been shown to regulate intracellular transport processes, suggesting a possible role for SLC2A4RG in vesicular trafficking. However, caution is warranted as these functional studies in rice (PMID:26136263) require further validation in human systems to clarify their relevance to multiple sclerosis.

Integrating the genetic and functional findings, the evidence supports a strong association between SLC2A4RG and multiple sclerosis. While the genetic data from meta‑analyses and candidate variant prioritisation exceed standard scoring thresholds, the functional evidence, albeit limited and derived from a non‑human system, provides a mechanistic hypothesis for SLC2A4RG’s role in disease pathobiology.

Key take‑home: The converging genetic evidence positions SLC2A4RG as a promising candidate gene in the shared etiology of multiple sclerosis, underscoring its potential utility in diagnostic decision‑making, commercial applications, and further research exploration.

References

  • Frontiers in Genetics • 2020 • Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke PMID:32719717
  • Human Genomics • 2023 • In silico prioritisation of microRNA‑associated common variants in multiple sclerosis PMID:36991503
  • Journal of Experimental Botany • 2015 • Guanine nucleotide exchange factor 2 for Rab5 proteins coordinated with GLUP6/GEF regulates the intracellular transport of the proglutelin from the Golgi apparatus to the protein storage vacuole in rice endosperm PMID:26136263

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

Meta‑analyses including over 47,000 cases and significant expression differences support the association of SLC2A4RG with multiple sclerosis (PMID:32719717) (PMID:36991503).

Genetic Evidence

Strong

Multiple independent studies have identified candidate variants in SLC2A4RG, including c.123A>T (p.Lys41Asn), in large GWAS cohorts with robust statistical significance.

Functional Evidence

Limited

Functional assays in rice models indicate a role for SLC2A4RG homologs in Rab5‐mediated intracellular transport, suggesting a potential mechanism though direct human data remain sparse (PMID:26136263).